Ad Law Access
News & Views: Dietary Supplement Advertising
This month we sent out the first edition of News & Views: Dietary Supplement Advertising . This newsletter is specifically for our clients marketing dietary supplements. We’ll cover developments ranging from FTC,…
Weight-Loss Claims: How Many Studies Does the FTC Really Think It Takes?
On Tuesday, the FTC announced that it has sent warning letters to 20 marketers of weight-loss dietary supplements. The letters question whether the companies possess adequate support for claims and describe the…
United States v. Bayer: Preventing or Treating Disease Claims
In recent years, the FTC and the Center for Science in the Public Interest (“CSPI”) seem to have seen disease claims everywhere, regardless of whether the FDA has deemed the same claims appropriate, non-disease…
FTC Urges FDA to Reconsider Homeopathic Regulatory Framework
In a comment filed last Friday, the Federal Trade Commission (FTC) responded to its sister-agency’s request for comments by urging the Food and Drug Administration (FDA) to reconsider how homeopathic drugs are…
FTC Resolves Case Against “Melanoma Detective” App Marketer
The FTC announced late last week that it resolved its case against the final defendant, Avrom Lasarow, in the “Melanoma Detective” app matters. The FTC alleged that claims that the apps could detect and diagnose…